| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |